American Journal of Psychiatry最新文献

筛选
英文 中文
Intermittent Theta Burst Stimulation With Adjunctive D-Cycloserine for Obsessive-Compulsive Disorder: A Randomized Clinical Trial. 辅助d-环丝氨酸间歇性θ波爆发刺激治疗强迫症:一项随机临床试验。
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2025-03-01 Epub Date: 2025-02-19 DOI: 10.1176/appi.ajp.20240181
Alexander McGirr, Jaeden Cole, Scott B Patten, Beverly Adams
{"title":"Intermittent Theta Burst Stimulation With Adjunctive D-Cycloserine for Obsessive-Compulsive Disorder: A Randomized Clinical Trial.","authors":"Alexander McGirr, Jaeden Cole, Scott B Patten, Beverly Adams","doi":"10.1176/appi.ajp.20240181","DOIUrl":"10.1176/appi.ajp.20240181","url":null,"abstract":"","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":" ","pages":"307-311"},"PeriodicalIF":15.1,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143447731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond Feared Outcomes: Exploring Sensory Phenomena as a Novel Therapeutic Target for OCD. 超越恐惧的结果:探索作为强迫症新治疗靶点的感觉现象。
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2025-03-01 DOI: 10.1176/appi.ajp.20241213
Dana E Díaz, Kate D Fitzgerald
{"title":"Beyond Feared Outcomes: Exploring Sensory Phenomena as a Novel Therapeutic Target for OCD.","authors":"Dana E Díaz, Kate D Fitzgerald","doi":"10.1176/appi.ajp.20241213","DOIUrl":"https://doi.org/10.1176/appi.ajp.20241213","url":null,"abstract":"","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":"182 3","pages":"234-236"},"PeriodicalIF":15.1,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143531163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Xanomeline-Trospium Treatment of Cognitive Impairments of Schizophrenia: Hope for Some, or Hope for All? 赛诺梅林-氨噻嘧啶治疗精神分裂症认知障碍:部分人的希望,还是所有人的希望?
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2025-03-01 DOI: 10.1176/appi.ajp.20241187
Daniel C Javitt
{"title":"Xanomeline-Trospium Treatment of Cognitive Impairments of Schizophrenia: Hope for Some, or Hope for All?","authors":"Daniel C Javitt","doi":"10.1176/appi.ajp.20241187","DOIUrl":"https://doi.org/10.1176/appi.ajp.20241187","url":null,"abstract":"","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":"182 3","pages":"237-239"},"PeriodicalIF":15.1,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143531171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmaco-Transcranial Magnetic Stimulation: Letting Mechanism Guide the Way. 药物-经颅磁刺激:让机制指引方向。
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2025-03-01 DOI: 10.1176/appi.ajp.20241151
Joshua C Brown, Noah S Philip
{"title":"Pharmaco-Transcranial Magnetic Stimulation: Letting Mechanism Guide the Way.","authors":"Joshua C Brown, Noah S Philip","doi":"10.1176/appi.ajp.20241151","DOIUrl":"10.1176/appi.ajp.20241151","url":null,"abstract":"","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":"182 3","pages":"240-242"},"PeriodicalIF":15.1,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143531168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin Treatment. 无法弥补的精神痛苦,迷幻药治疗的潜在适应症。
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2025-03-01 DOI: 10.1176/appi.ajp.20240121
Metten Somers, Floortje E Scheepers
{"title":"Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin Treatment.","authors":"Metten Somers, Floortje E Scheepers","doi":"10.1176/appi.ajp.20240121","DOIUrl":"https://doi.org/10.1176/appi.ajp.20240121","url":null,"abstract":"","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":"182 3","pages":"243-246"},"PeriodicalIF":15.1,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143531166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Six Years After Approval of Esketamine Nasal Spray for Serious Depression: Clinical Conundrums and Unanswered Questions. 重度抑郁症艾氯胺酮鼻喷雾剂获批6年后:临床难题和未解之谜。
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2025-03-01 DOI: 10.1176/appi.ajp.20241177
Sanjay J Mathew, Nicholas Murphy
{"title":"Six Years After Approval of Esketamine Nasal Spray for Serious Depression: Clinical Conundrums and Unanswered Questions.","authors":"Sanjay J Mathew, Nicholas Murphy","doi":"10.1176/appi.ajp.20241177","DOIUrl":"https://doi.org/10.1176/appi.ajp.20241177","url":null,"abstract":"","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":"182 3","pages":"227-230"},"PeriodicalIF":15.1,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143531169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Fresh Look at the Allostasis Theory of Addiction. 重新审视成瘾的适应平衡理论。
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2025-02-01 DOI: 10.1176/appi.ajp.20241106
Markus Heilig
{"title":"A Fresh Look at the Allostasis Theory of Addiction.","authors":"Markus Heilig","doi":"10.1176/appi.ajp.20241106","DOIUrl":"https://doi.org/10.1176/appi.ajp.20241106","url":null,"abstract":"","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":"182 2","pages":"142-144"},"PeriodicalIF":15.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143073342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders. 酒精奖励、刺激和负面影响在有或没有酒精使用障碍和抑郁症个体中的实时评估
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2025-02-01 DOI: 10.1176/appi.ajp.20240069
Andrea C King, Andrew M Fischer, John F Cursio, Nathan A Didier, Zoe Lee, Daniel J Fridberg
{"title":"Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders.","authors":"Andrea C King, Andrew M Fischer, John F Cursio, Nathan A Didier, Zoe Lee, Daniel J Fridberg","doi":"10.1176/appi.ajp.20240069","DOIUrl":"10.1176/appi.ajp.20240069","url":null,"abstract":"<p><strong>Objective: </strong>The allostasis theory states that, as addiction develops, alcohol is consumed to relieve negative affect rather than to produce positive effects. This study aimed to investigate the real-time subjective effects of alcohol in individuals with alcohol use disorder (AUD) and those prone to negative affect by virtue of having comorbid depressive disorder (DEP).</p><p><strong>Methods: </strong>Participants (N=221) completed high-resolution ecological momentary assessments during 3-hour monitoring of one alcohol drinking episode and one non-alcohol drinking episode in their natural environment. Participants also completed daily mood surveys and next-day surveys. Linear mixed-effect models were used to compare drinking behavior and subjective responses (stimulation, sedation, liking, wanting, negative affect) among 120 participants with AUD (AUD+; with depression [DEP+]: N=64, without depression [DEP-]: N=56) and 101 participants without AUD (AUD-; DEP+: N=45, DEP-: N=56).</p><p><strong>Results: </strong>During the monitoring period, participants with AUD consumed an average of 8.5 standard alcohol drinks (estimated blood alcohol concentration [eBAC]=0.115 g/dl) versus 3.7 drinks (eBAC=0.040 g/dl) for non-AUD participants. The AUD group, regardless of comorbid DEP, reported increases in stimulation and rewarding effects that persisted throughout most of the alcohol episode relative to the non-alcohol episode. To a lesser extent, alcohol relieved negative affect but this was not specific to AUD or DEP groups.</p><p><strong>Conclusions: </strong>Contrary to the allostasis model of addiction's emphasis on negative reinforcement drinking, findings demonstrated that people with AUD prone to negative affect displayed positive alcohol reinforcement with pronounced and prolonged sensitivity to alcohol's pleasurable effects, akin to their noncomorbid counterparts. The findings provided critical testing of addiction theories in the natural environment to enhance external validity.</p>","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":"182 2","pages":"187-197"},"PeriodicalIF":15.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143073469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding the Effects of Combined Lisdexamfetamine and Cognitive Behavior Therapy for Adults With Binge Eating Disorder. 了解利地安非他明联合认知行为治疗成人暴食症的效果。
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2025-02-01 DOI: 10.1176/appi.ajp.20241070
Tom Hildebrandt, Elizabeth Martin
{"title":"Understanding the Effects of Combined Lisdexamfetamine and Cognitive Behavior Therapy for Adults With Binge Eating Disorder.","authors":"Tom Hildebrandt, Elizabeth Martin","doi":"10.1176/appi.ajp.20241070","DOIUrl":"https://doi.org/10.1176/appi.ajp.20241070","url":null,"abstract":"","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":"182 2","pages":"149-150"},"PeriodicalIF":15.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143073474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder With Obesity: A Randomized Controlled Trial. 认知行为疗法和利地苯他明单独或联合治疗暴食症伴肥胖:一项随机对照试验。
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2025-02-01 Epub Date: 2024-12-11 DOI: 10.1176/appi.ajp.20230982
Carlos M Grilo, Valentina Ivezaj, Cenk Tek, Sydney Yurkow, Ashley A Wiedemann, Ralitza Gueorguieva
{"title":"Cognitive Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder With Obesity: A Randomized Controlled Trial.","authors":"Carlos M Grilo, Valentina Ivezaj, Cenk Tek, Sydney Yurkow, Ashley A Wiedemann, Ralitza Gueorguieva","doi":"10.1176/appi.ajp.20230982","DOIUrl":"10.1176/appi.ajp.20230982","url":null,"abstract":"<p><strong>Objective: </strong>Binge-eating disorder (BED) is a prevalent, costly public health problem associated with serious functional impairments and heightened rates of psychiatric and medical comorbidities. Few evidence-based treatments are currently available for BED. We tested the effectiveness of cognitive-behavioral therapy (CBT), lisdexamfetamine (LDX), and combined CBT+LDX, for BED comorbid with obesity.</p><p><strong>Methods: </strong>Randomized controlled trial was conducted March 2019 to September 2023 at a single site. N=141 patients with BED (83.7% women, mean age 43.6, mean BMI 38.6 kg/m<sup>2</sup>) were randomized to one of three 12-week treatments: CBT (N=47), LDX (N=47), or CBT+LDX (N=47); 87.2% completed independent posttreatment assessments.</p><p><strong>Results: </strong>Mixed models revealed binge-eating frequency decreased significantly in all treatments, with CBT+LDX having the largest reduction and significantly outperforming CBT and LDX, which did not differ. Intention-to-treat binge-eating remission rates differed significantly between treatments, with CBT+LDX having the highest remission rate (70.2%) followed by CBT (44.7%) and LDX (40.4%). Mixed models revealed percent weight loss increased significantly throughout treatment with LDX and CBT+LDX but remained unchanged in CBT. LDX and CBT+LDX had significantly greater percent weight loss than CBT starting after one month and through posttreatment. Intention-to-treat rates of attaining ≥5% weight loss differed across treatments, with LDX having the highest (53.2%), followed by CBT+LDX (42.6%) and CBT (4.3%). Analyses revealed significant reductions in eating-disorder psychopathology; CBT+LDX had largest reductions and significantly outperformed CBT and LDX.</p><p><strong>Conclusions: </strong>CBT, LDX, and CBT+LDX showed significant improvements in BED, with a consistent pattern of the combined CBT+LDX being superior to the two individual treatments, which differed little.</p>","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":" ","pages":"209-218"},"PeriodicalIF":15.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11786997/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142805847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信